darrp32
DAR-4 |
|||
| GW3895-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
DAR-1 |
|||
| GW7529-1 | Glentham Life Sciences | 1 | 152.2 EUR |
DAR-1 |
|||
| GW7529-25 | Glentham Life Sciences | 25 | 734.3 EUR |
DAR-1 |
|||
| GW7529-5 | Glentham Life Sciences | 5 | 284.3 EUR |
DAR-2 |
|||
| GW8659-1 | Glentham Life Sciences | 1 | 205.8 EUR |
DAR-2 |
|||
| GW8659-25 | Glentham Life Sciences | 25 | 1546.3 EUR |
DAR-2 |
|||
| GW8659-5 | Glentham Life Sciences | 5 | 423.4 EUR |
DAR-4T |
|||
| GW1186-1 | Glentham Life Sciences | 1 | 388.8 EUR |
DAR-4T |
|||
| GW1186-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
DAR-1T |
|||
| GW5595-1 | Glentham Life Sciences | 1 | 371.1 EUR |
DAR-1T |
|||
| GW5595-5 | Glentham Life Sciences | 5 | 1365.9 EUR |
DAR-2T |
|||
| GW5966-1 | Glentham Life Sciences | 1 | 222.3 EUR |
DAR-2T |
|||
| GW5966-5 | Glentham Life Sciences | 5 | 475.7 EUR |
DAR-4M |
|||
| GW9829-1 | Glentham Life Sciences | 1 | 388.8 EUR |
DAR-4M |
|||
| GW9829-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
DAR-4MT |
|||
| GW2770-1 | Glentham Life Sciences | 1 | 388.8 EUR |
DAR-4MT |
|||
| GW2770-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
Dar/ Rat Dar ELISA Kit |
|||
| ELI-34283r | Lifescience Market | 96 Tests | 1063.2 EUR |
DAR-2 Solution |
|||
| GW5599-1 | Glentham Life Sciences | 1 | 720.6 EUR |
DAR-4 Solution |
|||
| GW6996-1 | Glentham Life Sciences | 1 | 720.6 EUR |
DAR-1 Solution |
|||
| GW9719-1 | Glentham Life Sciences | 1 | 720.6 EUR |
Dars/ Rat Dars ELISA Kit |
|||
| ELI-46226r | Lifescience Market | 96 Tests | 1063.2 EUR |
DAR-1T Solution |
|||
| GW0136-1 | Glentham Life Sciences | 1 | 720.6 EUR |
DAR-4T Solution |
|||
| GW2484-1 | Glentham Life Sciences | 1 | 720.6 EUR |
DAR-4M Solution |
|||
| GW9618-1 | Glentham Life Sciences | 1 | 720.6 EUR |
DAR-4MT Solution |
|||
| GW2711-1 | Glentham Life Sciences | 1 | 720.6 EUR |
Dars2/ Rat Dars2 ELISA Kit |
|||
| ELI-29268r | Lifescience Market | 96 Tests | 1063.2 EUR |
Tips 50ul 103 mm dark green 10x96 |
|||
| E0030073630 | Scientific Laboratory Supplies | EACH | 91.2 EUR |
DARPP32 (DARPP32) Antibody |
|||
| abx232244-100ug | Abbexa | 100 ug | 577.2 EUR |
DARPP32 (DARPP32) Antibody |
|||
| abx037707-100ug | Abbexa | 100 ug | 469.2 EUR |
Tips PCR Clean 50uL 103 mm dark green 10x96 |
|||
| E0030073649 | Scientific Laboratory Supplies | EACH | 100.8 EUR |
KRIBIOLISA™ Daratumumab (DARZALEX™) ELISA |
|||
| KBI1028 | Krishgen | 12 × 8 wells | 2133 EUR |
DAR-M |
|||
| GW1128-1 | Glentham Life Sciences | 1 | 388.8 EUR |
DAR-M |
|||
| GW1128-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
[D-Arg25]-Neuropeptide Y, human, rat; [D-Arg25]-NPY, human, rat |
|||
| 5-00108 | CHI Scientific | 4 x 1mg | Ask for price |
DAR-MT |
|||
| GW1738-1 | Glentham Life Sciences | 1 | 388.8 EUR |
DAR-MT |
|||
| GW1738-5 | Glentham Life Sciences | 5 | 1436.2 EUR |
Shikari (Q-DAR) Daratumumab (Darzalex)Free drug ELISA kit |
|||
| DAR-FD-DAR | Matriks Biotek | 1x96-wells test plate | 1053.6 EUR |
|
Description: Enzyme Immunoassay for detection of freeDaratumumab (Darzalex) in human serum and plasma samples. |
|||
DARC siRNA |
|||
| 20-abx913572 | Abbexa |
|
|
DARC siRNA |
|||
| 20-abx913573 | Abbexa |
|
|
DARS siRNA |
|||
| 20-abx913576 | Abbexa |
|
|
DARS siRNA |
|||
| 20-abx913577 | Abbexa |
|
|
DARS siRNA |
|||
| 20-abx901412 | Abbexa |
|
|
DARPP-32 |
|||
| RA18015 | Neuromics | 100 ul | 579.6 EUR |
DARS2 siRNA |
|||
| 20-abx913574 | Abbexa |
|
|
DARS2 siRNA |
|||
| 20-abx913575 | Abbexa |
|
|
DARS2 siRNA |
|||
| 20-abx901411 | Abbexa |
|
|
darkroom |
|||
| VLCN6 | Consort | ea | 321.6 EUR |
Darunavir |
|||
| 10-021 | ProSci | 50 mg | 501.36 EUR |
|
Description: Darunavir is a highly potent HIV protease inhibitor (IC50=3-6nM, depending on laboratory HIV-1 strain), an antiretroviral medication used to treat and prevent HIV/AIDS. Darunavir is a second generation HIV-1 protease inhibitor that inhibits replication of various laboratory strains and clinical isolates of HIV-1, including those resistant to first generation protease inhibitors. It inhibits cell-free diffusion and cell-to-cell spread of HIV-1 in Jurkat cell populations. Formulations containing darunavir have been used in combination therapy for the treatment of HIV. The Darunavir ethanolate (Prod. No. AG-CR1-3724) formulation has some stability advantages compared to the free base Darunavir. Shown in a SARS-CoV-2 protease structure model study to potentially bind and inhibit the papain-like viral protease (PLVP) of SARS-CoV-2, responsible for COVID-19. |
|||
DARC Peptide |
|||
| 4069P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (CT) DARC peptide |
|||
DARC Peptide |
|||
| 4071P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (NT) DARC peptide |
|||
DARS Rabbit pAb |
|||
| A6574-100ul | Abclonal | 100 ul | 369.6 EUR |
DARS Rabbit pAb |
|||
| A6574-200ul | Abclonal | 200 ul | 550.8 EUR |
DARS Rabbit pAb |
|||
| A6574-20ul | Abclonal | 20 ul | 219.6 EUR |
DARS Rabbit pAb |
|||
| A6574-50ul | Abclonal | 50 ul | 267.6 EUR |
Darunavir |
|||
| A8206-5 | ApexBio | 5 mg | 142.8 EUR |
|
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions. |
|||
Darunavir |
|||
| A8206-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 254.4 EUR |
|
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions. |
|||
Darunavir |
|||
| A8206-50 | ApexBio | 50 mg | 518.4 EUR |
|
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions. |
|||
Darunavir |
|||
| A8206-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions. |
|||
D-Arabitol |
|||
| AB0097 | Bio Basic | 25g | 310.56 EUR |
D-Arabitol |
|||
| HY-N3686 | MedChemExpress | 10mM/1mL | 135.6 EUR |
Darunavir |
|||
| HY-17040 | MedChemExpress | 5mg | 300 EUR |
D-Arginine |
|||
| GM7267-1G | Glentham Life Sciences | 1 g | 69.6 EUR |
D-Arginine |
|||
| GM7267-25G | Glentham Life Sciences | 25 g | 246 EUR |
D-Arginine |
|||
| GM7267-5G | Glentham Life Sciences | 5 g | 112.8 EUR |
D-Arginine |
|||
| GM7267-1 | Glentham Life Sciences | 1 | 27.8 EUR |
D-Arginine |
|||
| GM7267-25 | Glentham Life Sciences | 25 | 174 EUR |
D-Arginine |
|||
| GM7267-5 | Glentham Life Sciences | 5 | 63.3 EUR |
Darunavir |
|||
| GP5767-10 | Glentham Life Sciences | 10 | 67.2 EUR |
Darunavir |
|||
| GP5767-50 | Glentham Life Sciences | 50 | 234.9 EUR |